On March 28, Progenity Inc. (PROG) declared its financial results for Q4 and fiscal 2021 after the market close. Consequently, the not-so-god results caused the
Progenity Inc. (PROG) is a molecular and specialized diagnostic tests provider, based in San Diego, CA. On January 25, the company announced the addition of
Progenity, Inc. (PROG) stock gained value in pre-market after they announced the financial statement of their 3rd quarter on 10 November. Progenity, Inc. (PROG) stock
Progenity Inc. (PROG) stock prices soared by a massive 28.92% as of the market closing on June 11th, 2021, bringing the price per share up
Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter
Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.